International prospective observational study on intracranial pressure in intensive care (ICU)

The SYNAPSE-ICU study protocol

Giuseppe Citerio, Lara Prisco, Mauro Oddo, Geert Meyfroidt, Raimund Helbok, Nino Stocchetti, Fabio Taccone, Jean Louis Vincent, Chiara Robba, Francesca Elli, Elisa Sala, Alessia Vargiolu, Hester Lingsma

Research output: Contribution to journalArticle

Abstract

Introduction Intracranial pressure (ICP) monitoring is commonly used in neurocritical care patients with acute brain injury (ABI). Practice about indications and use of ICP monitoring in patients with ABI remains, however, highly variable in high-income countries, while data on ICP monitoring in low and middle-income countries are scarce or inconsistent. The aim of the SYNAPSE-ICU study is to describe current practices of ICP monitoring using a worldwide sample and to quantify practice variations in ICP monitoring and management in neurocritical care ABI patients. Methods and analysis The SYNAPSE-ICU study is a large international, prospective, observational cohort study. From March 2018 to March 2019, all patients fulfilling the following inclusion criteria will be recruited: age >18 years; diagnosis of ABI due to primary haemorrhagic stroke (subarachnoid haemorrhage or intracranial haemorrhage) or traumatic brain injury; Glasgow Coma Score (GCS) with no eye opening (Eyes response=1) and Motor score ≤5 (not following commands) at ICU admission, or neuro-worsening within the first 48 hours with no eye opening and a Motor score decreased to ≤5. Data related to clinical examination (GCS, pupil size and reactivity, Richmond Agitation-Sedation Scale score, neuroimaging) and to ICP interventions (Therapy Intensity Levels) will be recorded on admission, and at day 1, 3 and 7. The Glasgow Outcome Scale Extended (GOSE) will be collected at discharge from ICU and from hospital and at 6-month follow-up. The impact of ICP monitoring and ICP-driven therapy on GOSE will be analysed at both patient and ICU level. Ethics and dissemination The study has been approved by the Ethics Committee 'Brianza' at the Azienda Socio Sanitaria Territoriale (ASST)-Monza (approval date: 21 November 2017). Each National Coordinator will notify the relevant ethics committee, in compliance with the local legislation and rules. Data will be made available to the scientific community by means of abstracts submitted to the European Society of Intensive Care Medicine annual conference and by scientific reports and original articles submitted to peer-reviewed journals.

Original languageEnglish
Article numbere026552
JournalBMJ Open
Volume9
Issue number4
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Intracranial Pressure
Critical Care
Observational Studies
Prospective Studies
Brain Injuries
Glasgow Outcome Scale
Ethics Committees
Coma
Intracranial Hemorrhages
Physiologic Monitoring
Subarachnoid Hemorrhage
Pupil
Legislation
Neuroimaging
Ethics
Patient Care
Cohort Studies
Stroke
Therapeutics

Keywords

  • acute brain injury
  • intracranial pressure monitoring
  • traumatic brain injury

ASJC Scopus subject areas

  • Medicine(all)

Cite this

International prospective observational study on intracranial pressure in intensive care (ICU) : The SYNAPSE-ICU study protocol. / Citerio, Giuseppe; Prisco, Lara; Oddo, Mauro; Meyfroidt, Geert; Helbok, Raimund; Stocchetti, Nino; Taccone, Fabio; Vincent, Jean Louis; Robba, Chiara; Elli, Francesca; Sala, Elisa; Vargiolu, Alessia; Lingsma, Hester.

In: BMJ Open, Vol. 9, No. 4, e026552, 01.04.2019.

Research output: Contribution to journalArticle

Citerio, G, Prisco, L, Oddo, M, Meyfroidt, G, Helbok, R, Stocchetti, N, Taccone, F, Vincent, JL, Robba, C, Elli, F, Sala, E, Vargiolu, A & Lingsma, H 2019, 'International prospective observational study on intracranial pressure in intensive care (ICU): The SYNAPSE-ICU study protocol', BMJ Open, vol. 9, no. 4, e026552. https://doi.org/10.1136/bmjopen-2018-026552
Citerio, Giuseppe ; Prisco, Lara ; Oddo, Mauro ; Meyfroidt, Geert ; Helbok, Raimund ; Stocchetti, Nino ; Taccone, Fabio ; Vincent, Jean Louis ; Robba, Chiara ; Elli, Francesca ; Sala, Elisa ; Vargiolu, Alessia ; Lingsma, Hester. / International prospective observational study on intracranial pressure in intensive care (ICU) : The SYNAPSE-ICU study protocol. In: BMJ Open. 2019 ; Vol. 9, No. 4.
@article{558adcf4263e4691af946ac6509f1a9c,
title = "International prospective observational study on intracranial pressure in intensive care (ICU): The SYNAPSE-ICU study protocol",
abstract = "Introduction Intracranial pressure (ICP) monitoring is commonly used in neurocritical care patients with acute brain injury (ABI). Practice about indications and use of ICP monitoring in patients with ABI remains, however, highly variable in high-income countries, while data on ICP monitoring in low and middle-income countries are scarce or inconsistent. The aim of the SYNAPSE-ICU study is to describe current practices of ICP monitoring using a worldwide sample and to quantify practice variations in ICP monitoring and management in neurocritical care ABI patients. Methods and analysis The SYNAPSE-ICU study is a large international, prospective, observational cohort study. From March 2018 to March 2019, all patients fulfilling the following inclusion criteria will be recruited: age >18 years; diagnosis of ABI due to primary haemorrhagic stroke (subarachnoid haemorrhage or intracranial haemorrhage) or traumatic brain injury; Glasgow Coma Score (GCS) with no eye opening (Eyes response=1) and Motor score ≤5 (not following commands) at ICU admission, or neuro-worsening within the first 48 hours with no eye opening and a Motor score decreased to ≤5. Data related to clinical examination (GCS, pupil size and reactivity, Richmond Agitation-Sedation Scale score, neuroimaging) and to ICP interventions (Therapy Intensity Levels) will be recorded on admission, and at day 1, 3 and 7. The Glasgow Outcome Scale Extended (GOSE) will be collected at discharge from ICU and from hospital and at 6-month follow-up. The impact of ICP monitoring and ICP-driven therapy on GOSE will be analysed at both patient and ICU level. Ethics and dissemination The study has been approved by the Ethics Committee 'Brianza' at the Azienda Socio Sanitaria Territoriale (ASST)-Monza (approval date: 21 November 2017). Each National Coordinator will notify the relevant ethics committee, in compliance with the local legislation and rules. Data will be made available to the scientific community by means of abstracts submitted to the European Society of Intensive Care Medicine annual conference and by scientific reports and original articles submitted to peer-reviewed journals.",
keywords = "acute brain injury, intracranial pressure monitoring, traumatic brain injury",
author = "Giuseppe Citerio and Lara Prisco and Mauro Oddo and Geert Meyfroidt and Raimund Helbok and Nino Stocchetti and Fabio Taccone and Vincent, {Jean Louis} and Chiara Robba and Francesca Elli and Elisa Sala and Alessia Vargiolu and Hester Lingsma",
year = "2019",
month = "4",
day = "1",
doi = "10.1136/bmjopen-2018-026552",
language = "English",
volume = "9",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - International prospective observational study on intracranial pressure in intensive care (ICU)

T2 - The SYNAPSE-ICU study protocol

AU - Citerio, Giuseppe

AU - Prisco, Lara

AU - Oddo, Mauro

AU - Meyfroidt, Geert

AU - Helbok, Raimund

AU - Stocchetti, Nino

AU - Taccone, Fabio

AU - Vincent, Jean Louis

AU - Robba, Chiara

AU - Elli, Francesca

AU - Sala, Elisa

AU - Vargiolu, Alessia

AU - Lingsma, Hester

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Introduction Intracranial pressure (ICP) monitoring is commonly used in neurocritical care patients with acute brain injury (ABI). Practice about indications and use of ICP monitoring in patients with ABI remains, however, highly variable in high-income countries, while data on ICP monitoring in low and middle-income countries are scarce or inconsistent. The aim of the SYNAPSE-ICU study is to describe current practices of ICP monitoring using a worldwide sample and to quantify practice variations in ICP monitoring and management in neurocritical care ABI patients. Methods and analysis The SYNAPSE-ICU study is a large international, prospective, observational cohort study. From March 2018 to March 2019, all patients fulfilling the following inclusion criteria will be recruited: age >18 years; diagnosis of ABI due to primary haemorrhagic stroke (subarachnoid haemorrhage or intracranial haemorrhage) or traumatic brain injury; Glasgow Coma Score (GCS) with no eye opening (Eyes response=1) and Motor score ≤5 (not following commands) at ICU admission, or neuro-worsening within the first 48 hours with no eye opening and a Motor score decreased to ≤5. Data related to clinical examination (GCS, pupil size and reactivity, Richmond Agitation-Sedation Scale score, neuroimaging) and to ICP interventions (Therapy Intensity Levels) will be recorded on admission, and at day 1, 3 and 7. The Glasgow Outcome Scale Extended (GOSE) will be collected at discharge from ICU and from hospital and at 6-month follow-up. The impact of ICP monitoring and ICP-driven therapy on GOSE will be analysed at both patient and ICU level. Ethics and dissemination The study has been approved by the Ethics Committee 'Brianza' at the Azienda Socio Sanitaria Territoriale (ASST)-Monza (approval date: 21 November 2017). Each National Coordinator will notify the relevant ethics committee, in compliance with the local legislation and rules. Data will be made available to the scientific community by means of abstracts submitted to the European Society of Intensive Care Medicine annual conference and by scientific reports and original articles submitted to peer-reviewed journals.

AB - Introduction Intracranial pressure (ICP) monitoring is commonly used in neurocritical care patients with acute brain injury (ABI). Practice about indications and use of ICP monitoring in patients with ABI remains, however, highly variable in high-income countries, while data on ICP monitoring in low and middle-income countries are scarce or inconsistent. The aim of the SYNAPSE-ICU study is to describe current practices of ICP monitoring using a worldwide sample and to quantify practice variations in ICP monitoring and management in neurocritical care ABI patients. Methods and analysis The SYNAPSE-ICU study is a large international, prospective, observational cohort study. From March 2018 to March 2019, all patients fulfilling the following inclusion criteria will be recruited: age >18 years; diagnosis of ABI due to primary haemorrhagic stroke (subarachnoid haemorrhage or intracranial haemorrhage) or traumatic brain injury; Glasgow Coma Score (GCS) with no eye opening (Eyes response=1) and Motor score ≤5 (not following commands) at ICU admission, or neuro-worsening within the first 48 hours with no eye opening and a Motor score decreased to ≤5. Data related to clinical examination (GCS, pupil size and reactivity, Richmond Agitation-Sedation Scale score, neuroimaging) and to ICP interventions (Therapy Intensity Levels) will be recorded on admission, and at day 1, 3 and 7. The Glasgow Outcome Scale Extended (GOSE) will be collected at discharge from ICU and from hospital and at 6-month follow-up. The impact of ICP monitoring and ICP-driven therapy on GOSE will be analysed at both patient and ICU level. Ethics and dissemination The study has been approved by the Ethics Committee 'Brianza' at the Azienda Socio Sanitaria Territoriale (ASST)-Monza (approval date: 21 November 2017). Each National Coordinator will notify the relevant ethics committee, in compliance with the local legislation and rules. Data will be made available to the scientific community by means of abstracts submitted to the European Society of Intensive Care Medicine annual conference and by scientific reports and original articles submitted to peer-reviewed journals.

KW - acute brain injury

KW - intracranial pressure monitoring

KW - traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85064976147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064976147&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2018-026552

DO - 10.1136/bmjopen-2018-026552

M3 - Article

VL - 9

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 4

M1 - e026552

ER -